Anti-ACEH antibody produced in rabbit

Anti-ACEH antibody produced in rabbit Struktur
CAS-Nr.
Englisch Name:
Anti-ACEH antibody produced in rabbit
Synonyma:
Anti-ACEH;Anti-ACE2;Anti-DKFZP434A014;Anti-ACEH antibody produced in rabbit;Anti-ACE2 antibody produced in rabbit;Anti-ACE-related carboxypeptidase antibody produced in rabbit;Anti-Angiotensin I converting enzyme (peptidyl-dipeptidase A) 2;Anti-Angiotensin-converting enzyme homolog antibody produced in rabbit;Anti-Angiotensin-converting enzyme 2 precursor antibody produced in rabbit
CBNumber:
CB02882888
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Anti-ACEH antibody produced in rabbit Eigenschaften

storage temp. 
-20°C
Aggregatzustand
buffered aqueous solution

Sicherheit

Anti-ACEH antibody produced in rabbit Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

All Prestige Antibodies?Powered by Atlas Antibodies is developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org). Each antibody is tested by immunohistochemistry against hundreds of normal and disease tissues. These images can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit .

Allgemeine Beschreibung

Angiotensin-converting enzyme-2 (ACE2) is a homolog of angiotensin-I converting enzyme (ACE). ACE2 is a member of the renin-angiotensin system (RAS) which performs functions similar to carboxypeptidase. This 805 amino acid protein is localized in human kidney. The ACE2 gene is located at human chromosome Xp22.2. It contains a N-terminal peptidase domain (PD) and the C-terminal collectrin-like domain (CLD).

Biochem/physiol Actions

Angiotensin-converting enzyme (ACE2) catalyzes the degradation of angiotensin (Ang) II to Ang (1-7). The deficiency ACE2 or its inhibition by ang II is implicated in the pathogenesis of cardiac hypertrophy and myocardial dysfunction. ACE2 is multifunctional and is incapable of hydrolyzing bradykinin. In patients with CTD (connective tissue disease), serum autoantibodies suppress ACE2, which leads to a decrease in the physiological levels of vasoprotective agent Ang (1-7) in the vascular milieu. Activation or administration of ACE2 in patients with CTD may serve as a therapeutic method for treating pulmonary arterial hypertension (PAH), or persistent digital ischemia. It also plays a regulatory role in lung diseases and pulmonary fibrosis. The human ACE2 receptor is recognized by severe acute respiratory syndrome (SARS-CoV) coronaviruses (CoVs) 2. This interaction paves a way for the transmission of infection.

Anti-ACEH antibody produced in rabbit Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Anti-ACEH antibody produced in rabbit Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 22)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Sigma-Aldrich 021-61415566 800-8193336
orderCN@merckgroup.com China 51471 80
Shanghai guandao biology engineering co., ltd 18818239863 18818239863
3171921642@qq.com China 8889 58
Shanghai Yiyan Biotechnology Co. , Ltd. 021-69985186 13611928337
3427709316@qq.com China 7979 58

  • Anti-ACE2 antibody produced in rabbit
  • Anti-ACEH antibody produced in rabbit
  • Anti-ACE-related carboxypeptidase antibody produced in rabbit
  • Anti-Angiotensin-converting enzyme 2 precursor antibody produced in rabbit
  • Anti-Angiotensin-converting enzyme homolog antibody produced in rabbit
  • Anti-ACEH
  • Anti-Angiotensin I converting enzyme (peptidyl-dipeptidase A) 2
  • Anti-DKFZP434A014
  • Anti-ACE2
Copyright 2019 © ChemicalBook. All rights reserved